LAVSX
Price
$16.21
Change
+$0.02 (+0.12%)
Updated
Aug 19 closing price
Net Assets
2.03B
VVIAX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

LAVSX vs VVIAX

Header iconLAVSX vs VVIAX Comparison
Open Charts LAVSX vs VVIAXBanner chart's image
Lord Abbett Fundamental Equity R4
Price$16.21
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets2.03B
Vanguard Value Index Adm
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
LAVSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVSX vs. VVIAX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVSX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. LAVSX (2.03B). VVIAX pays higher dividends than LAVSX: VVIAX (2.18) vs LAVSX (0.82). LAVSX was incepted earlier than VVIAX: LAVSX (10 years) vs VVIAX (25 years). LAVSX (0.95) is less costly to investors than VVIAX (0.05). LAVSX is a more actively managed with annual turnover of: 39.00 vs. VVIAX (9.00). LAVSX has a lower initial minimum investment than VVIAX: LAVSX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.59 vs. LAVSX (5.94). VVIAX return over 5 years is better than : 70.19 vs. LAVSX (54.04).
LAVSXVVIAXLAVSX / VVIAX
Total Expense Ratio0.950.051,900%
Annual Report Gross Expense Ratio0.950.051,900%
Fund Existence10 years25 years-
Gain YTD8.2226.532126%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.03B196B1%
Annual Yield % from dividends0.822.1838%
Returns for 1 year5.947.5978%
Returns for 3 years29.2727.03108%
Returns for 5 years54.0470.1977%
Returns for 10 years36.36127.4529%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA6.160.20
+3.27%
Verrica Pharmaceuticals Inc
ARCB71.830.37
+0.52%
ArcBest Corp
FVNNU10.50-0.04
-0.38%
Future Vision II Acquisition Corp.
AM17.55-0.36
-2.01%
Antero Midstream Corp
CAPR7.70-0.27
-3.39%
Capricor Therapeutics